HomeNewsDrug Discovery & Development

Evotec Announces Progress in its Collaboration with Bristol Myers Squibb

Evotec Announces Progress in its Collaboration with Bristol Myers Squibb

Evotec has announced progress within the company’s strategic partnership with Bristol Myers Squibb, further bolstering the joint pipeline of advanced neuroscience programmes.

Evotec receives a USD 25 million payment to progress further research.

Evotec and Bristol Myers Squibb entered their strategic neuroscience collaboration in December 2016 to identify disease-modifying treatments for a broad range of neurodegenerative diseases where there remains a significant unmet medical need for therapies that slow down or reverse disease progression. The progress announced here leverages Evotec’s PanOmics platform in conjunction with patient-derived disease models, which is one of the largest and most sophisticated platforms in the industry.

The partnership has generated a promising pipeline of discovery to clinical-stage programmes. The first programme, EVT8683, was in-licensed by Bristol Myers Squibb in September 2021 as BMS-986419. In March 2023, Bristol Myers Squibb and Evotec extended and expanded their partnership for an additional 8 years.

Dr Cord Dohrmann, Chief Scientific Officer of Evotec, said, “The achieved milestone underlines the productive nature of our neuroscience partnership with Bristol Myers Squibb. Using our PanOmics-driven drug discovery platform we are targeting neurodegenerative diseases with tremendous unmet medical needs. Beyond BMS-986419, we are very excited to advance yet another programme towards the clinic development in 2026.”

More news about: drug discovery & development | Published by Aishwarya | August - 12 - 2024 | 206

Last news about this category


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members